How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.
In by Heather DelCarpini
How Glytec’s evidence strategy achieves improvements in lengths of stay, readmissions, infections and costs. AJMC interviews Dr. Andrew Rhinehart, Chief Medical Officer.
